As per the research report, the size of the Europe Spine Biologics Market is valued at USD 660 million in 2019 and estimated to be growing at a CAGR of 4.3%, to reach USD 810 million by 2024 during the forecast period 2019-2024.
Spine biologics are used during spine fusion surgery for the treatment of spinal deformities such as trauma, tumors, degenerative disc disease, and spinal cord injuries by stimulating bone growth formation through the inflammatory stage, repair stage, and remodeling stage. Biologics help in faster recovery and activate cellular growth. Therefore, the surge in the number of spinal fusion surgeries has fueled the adoption of biologics.
Spine Biologics market is growing due to advancement in technology as well as demand for better minimally surgical procedures, which make it more convenient for both the patient and doctor. Factors such as a rise in the prevalence of diseases due to the aging population and increased government funding are also driving the overall market. The major factors restraining the growth of the market are the high healthcare costs for such procedures, lack of expert professionals and unfavorable reimbursement scenarios.
This research report segmented and sub-segmented into the following categories:
The bone grafts substitute segment accounted for a major share of the market.
Key players operating in the Europe Spine Biologics Market profiled in this report are Alphatec Holdings, Inc., Depuy Synthes (Johnson & Johnson), Exactech, Inc., Globus Medical, Inc., Medtronic plc, NuVasive, Inc., Orthofix International N.V., RTI Surgical, Inc., SeaSpine, and Zimmer Biomet Holdings, Inc.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Surgery type
5.1.2 Anterior Cervical Discectomy and Fusion
5.1.3 Posterior Lumbar Interbody Fusion
5.1.4 Transforaminal Lumbar Interbody Fusion
5.1.5 Anterior Lumbar Interbody Fusion
5.1.6 Lateral Lumbar Interbody Fusion
5.1.8 Y-o-Y Growth Analysis, By surgery type
5.1.9 Market Attractiveness Analysis, By surgery type
5.1.10 Market Share Analysis, By surgery type
5.2 Product type
5.2.2 Bone graft
5.2.3 Bone graft substitutes
22.214.171.124 Synthetic bone grafts
126.96.36.199 Demineralized bone matrix
188.8.131.52 Bone Morphogenetic proteins
5.2.4 Platelet rich plasma
5.2.5 Bone marrow aspitaye therapy
5.2.6 Y-o-Y Growth Analysis, By Product type
5.2.7 Market Attractiveness Analysis, By Product type
5.2.8 Market Share Analysis, By Product type
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
184.108.40.206 By Geographical Area
220.127.116.11 By Surgery type
18.104.22.168 By Product Type
6.1.4 Market Attractiveness Analysis
22.214.171.124 By Geographical Area
126.96.36.199 By Surgery type
188.8.131.52 By Product Type
6.1.5 Market Share Analysis
184.108.40.206 By Geographical Area
220.127.116.11 By Surgery type
18.104.22.168 By Product Type
7. Strategic Analysis
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Alphatec Holdings Inc.
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Depuy Synthes
8.3 Exactech Inc.
8.4 Globus Medical Inc.
8.5 Medtronic plc.
8.6 NuVasive Inc.
8.7 Orthofix International N.V.
8.8 RTI Surgical Inc.
8.10 Zimmer Biomet Holdings Inc.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures